Table 2 Antibacterial activity of the safrole oil versus the safrole nanoemulgel and amoxicillin as a positive control
Name | Negative control | Amoxicillin 750 (mm) | Safrole oil (mm) | Safrole nanoemulgel (mm) |
|---|---|---|---|---|
Enterococcus faecium (ATCC 700221) | Resistance (No effect) | 40.0 ± 0.70 | 11.0 ± 0.72 | 19.0 ± 1.40 |
E. Coli (ATCC 25922) | Resistance (No effect) | 33.0 ± 0.81 | Resistance (No effect) | Resistance (No effect) |
Klebsiella (ATCC 13883) | Resistance (No effect) | 18.0 ± 1.41 | Resistance (No effect) | Partial resistance (Inhibition but the zone was not clear) |
Pseudomonas aeruginosa (ATCC 9027) | Resistance (No effect) | 40.0 ± 0.70 | 12.5 ± 0.71 | 20 ± 1.10 |
S. aureus (ATCC 25923) | Resistance (No effect) | 42.0 ± 0.70 | Partial resistance (Inhibition but the zone was not clear) | 13.0 ± 1.41 |
MRSA (Clinically strain) | Resistance (No effect) | 26.0 ± 1.41 | Partial resistance (Inhibition but the zone was not clear) | 14.5 ± 1.21 |
Proteus vulgaris (ATCC 8427) | Resistance (No effect) | 38.0 ± 2.80 | 11.5 ± 0.70 | 17 ± 0.5 |
Candida | Resistance (No effect) | Resistance (No effect) | 17.0 ± 0.80 | 22.0 ± 1.70 |